HTA2: Advancing HTA Expertise in Saudi Arabia Forum is a 5-month applied training program that builds on HTA1 and takes participants from theory to practice. Through virtual workshops series, online simulations, and a live capstone summit in Riyadh, delegates learn how to develop, evaluate, and present HTA dossiers that align with MOH, SFDA, and CNHI priorities and support Vision 2030 health system goals.
By the end of this program, participants will be able to:
Sign up for all HTA2 modules using the registration form. Please keep the following in mind:
This introductory session provides a short refresh of key Wave 1 concepts, followed by a focused workshop on effective communication and dossier writing. Participants will learn how to present evidence clearly, structure dossier components, and align communication with KSA HTA expectations before moving into the more technical modules that follow
By the end of this workshop, participants will be able to:
This module introduces participants to the strategic use of data when planning and developing an HTA submission. Building on the communication and writing foundations from Workshop 1, this session focuses on how to identify, select, and frame the evidence needed for a strong, KSA-aligned dossier. Participants will learn how to determine the right data sources, anticipate payer and evaluator expectations, and create a coherent data plan that supports later modules on budget impact, value narrative, and evaluation.
By the end of this workshop, participants will be able to:
In this module, participants learn how to translate evidence into a clear, Saudi-specific Budget Impact Analysis (BIA) — a core component of any HTA submission. This session teaches delegates how to construct credible budget impact projections that support policymaker and evaluator interpretations. The goal is to equip participants with the skills needed to produce decision-relevant BIAs that support payer alignment, pricing discussions, and later stages of dossier development.
By the end of this workshop, participants will be able to:
Module 4 teaches participants how to craft a clear and persuasive value narrative that connects clinical evidence, economic findings, and local system priorities. Building on the BIA developed in Module 3 and the evidence planning from Module 2, this session focuses on how to communicate value in a way that aligns with the needs of SFDA, MOH, and other decision makers. Participants learn how to frame benefits, address uncertainties, and present a coherent story that strengthens the overall dossier.
By the end of this workshop, participants will be able to:
Module 5 brings together everything participants have built so far. This session focuses on how to assemble a complete, submission-ready HTA dossier that aligns with the requirements and expectations of SFDA and MOH.
This session teaches delegates how HTA reviewers in the KSA assess dossiers, apply scoring criteria, and identify strengths and weaknesses in submissions.
Participants will gain a deeper understanding of what decision-makers look for, how evidence is weighed, and what can influence pricing and reimbursement outcomes.
This module also prepares participants for the Capstone Mega Forum in Riyadh on June 5-6.
Note: Attendance for the in-person event will be through direct invitation and subject to criteria of inclusion.
Aligning public sector leadership with the National HTA Vision, bridging the gap between regulatory guidelines and practical procurement, and establishing a common ground for pricing transparency.
Translating HTA theory into actionable results through simulation labs and defining the specific criteria required for successful formulary inclusion in the 2026/27 cycle.